Wei, Chih-Jen
Crank, Michelle C.
Shiver, John
Graham, Barney S.
Mascola, John R.
Nabel, Gary J. http://orcid.org/0000-0003-0619-4419
Article History
Accepted: 16 December 2019
First Online: 14 February 2020
Change Date: 13 March 2020
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41573-020-0066-8
Competing interests
: C.-J.W., J.S., and G.J.N. are employees and stock owners of Sanofi, whose subsidiary Sanofi-Pasteur is a major influenza vaccine producer and has issued patents and pending filed patent applications on various influenza vaccine technologies. C.-J.W and G.J.N. are inventors of gene-based and nanoparticle-based influenza vaccines that have been filed by either Sanofi or the US government. J.R.M. and B.S.G. are employees of the US government, which has issued patents and filed patent applications on various vaccines including ferritin nanoparticle-based influenza vaccines mentioned in this article. The other authors declare no competing interests.
Free to read: This content has been made available to all.